Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 23, 2023 - Issue 7
Submit an article Journal homepage
1,637
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Head and neck atopic dermatitis: still a challenging manifestation in the biologic era

Niccolò Goria Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy;b UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario a Gemelli IRCCS, Rome, ItalyORCID Iconhttps://orcid.org/0000-0003-1987-0623View further author information
ORCID Icon,
Elena Ippolitia Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy;b UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario a Gemelli IRCCS, Rome, ItalyView further author information
,
Ketty Perisa Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy;b UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario a Gemelli IRCCS, Rome, ItalyORCID Iconhttps://orcid.org/0000-0002-5237-0463View further author information
ORCID Icon &
Andrea Chiricozzia Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy;b UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario a Gemelli IRCCS, Rome, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6739-0387View further author information
ORCID Icon
Pages 575-577 | Received 24 Apr 2023, Accepted 08 Jun 2023, Published online: 14 Jun 2023

References

  • Yew YW, Thyssen JP, Silverberg JI. A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics. J Am Acad Dermatol. 2019;80(2):390–401. doi: 10.1016/j.jaad.2018.09.035
  • Lio PA, Wollenberg A, Thyssen JP, et al. Impact of atopic dermatitis lesion location on quality of life in adult patients in a real-world study. J Drugs Dermatol. 2020;19(10):943–948. doi: 10.36849/JDD.2020.5422
  • Ribero S, Puglisi B, Giura MT, et al. Head and neck severity index is associated to a significant worsening of quality of life in atopic dermatitis patients. Exp Dermatol. 2021;30(11):1717–1718. doi: 10.1111/exd.14368
  • Calzavara Pinton P, Cristaudo A, Foti C, et al. Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMast), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA). G Ital Dermatol Venereol. 2018;153(2):133–145. doi: 10.23736/S0392-0488.17.05892-8
  • Jaros J, Hendricks AJ, Shi VY, et al. A practical approach to recalcitrant face and neck dermatitis in atopic dermatitis. Dermatitis. 2020;31(3):169–177. doi: 10.1097/DER.0000000000000590
  • Raffi J, Suresh R, Botto N, et al. The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: a retrospective chart review. J Am Acad Dermatol. 2020;82(1):132–138. doi: 10.1016/j.jaad.2019.09.028
  • Chiricozzi A, Gori N, Di Nardo L, et al. Therapeutic impact and management of persistent head and neck atopic dermatitis in dupilumab-treated patients. Dermatology. 2022;238(4):717–724. doi: 10.1159/000519361
  • Cather J, Young M, DiRuggiero DC, et al. A review of phase 3 trials of dupilumab for the treatment of atopic dermatitis in adults, adolescents, and children aged 6 and up. Dermatol Ther (Heidelb). 2022;12(9):2013–2038. doi: 10.1007/s13555-022-00778-y
  • Jo CE, Finstad A, Georgakopoulos JR, et al. Facial and neck erythema associated with dupilumab treatment: a systematic review. J Am Acad Dermatol. 2021;84(5):1339–1347. doi: 10.1016/j.jaad.2021.01.012
  • Blauvelt A, Rosmarin D, Bieber T, et al. Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials. Br J Dermatol. 2019;181(1):196–197. doi: 10.1111/bjd.17703
  • Lauvelt A, de Bruin-Weller M, Simpson EL, et al. Dupilumab with topical corticosteroids provides rapid and sustained improvement in adults with moderate-to-severe atopic dermatitis across anatomic regions over 52 weeks. Dermatol Ther (Heidelb). 2022;12(1):223–231. doi: 10.1007/s13555-021-00638-1
  • Vittrup I, Krogh NS, Larsen HHP, et al. A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis: ineffectiveness in head-and-neck dermatitis. J Eur Acad Dermatol Venereol. 2023;37(5):1046–1055. doi: 10.1111/jdv.18849
  • Ashbaugh AG, Murase EM, Raffi J, et al. Characterization of residual facial dermatitis during dupilumab therapy: a retrospective chart review to delineate the potential role of expanded series patch testing. Dermatitis. 2022;33(1):51–61. doi: 10.1097/DER.0000000000000801
  • Gori N, Chiricozzi A, Malvaso D, et al. Successful combination of systemic agents for the treatment of atopic dermatitis resistant to dupilumab therapy. Dermatology. 2021;237(4):535–541. doi: 10.1159/000512890
  • Gori N, Ippoliti E, Antonelli F, et al. Successful response of upadacitinib in the treatment of atopic dermatitis lesions involving sensitive and visible areas resistant to dupilumab. Clin Exp Dermatol. 2023 Feb 1;p. llad040. doi: 10.1093/ced/llad040

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.